To further confirm that TGF-β promotes EMT in a dose dependent way, both 10 ng/ml and 20 ng/ml concentrations of the recombinant protein was added into both CNE-1 and 6–10B NPC cells. The gene discussed is TGFB1; the disease is nasopharyngeal carcinoma.